{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:03:45Z","timestamp":1767985425012,"version":"3.49.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Viruses"],"DOI":"10.1038\/s44298-025-00163-4","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:48:12Z","timestamp":1767966492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["K5 polysaccharides inhibit SARS-CoV-2 infection by preventing spike-proteolytic priming"],"prefix":"10.1038","volume":"4","author":[{"given":"Maria","family":"Milanesi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Urbinati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liv","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasqua","family":"Oreste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Zani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaldo","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Caccuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibor","family":"Laketa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Chlanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca C.","family":"Wade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Rusnati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Paiardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"163_CR1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.imj.2023.08.005","volume":"2","author":"MA Islam","year":"2023","unstructured":"Islam, M. A. A review of SARS-CoV-2 variants and vaccines: Viral properties, mutations, vaccine efficacy, and safety. Infect. Med. ((Beijing)) 2, 247\u2013261 (2023).","journal-title":"Infect. Med. ((Beijing))"},{"key":"163_CR2","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41586-020-2665-2","volume":"588","author":"Z Ke","year":"2020","unstructured":"Ke, Z. et al. Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature 588, 498\u2013502 (2020).","journal-title":"Nature"},{"key":"163_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181, 271\u2013280.e278 (2020).","journal-title":"Cell"},{"key":"163_CR4","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260\u20131263 (2020).","journal-title":"Science"},{"key":"163_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell 181, 281\u2013292.e286 (2020).","journal-title":"Cell"},{"key":"163_CR6","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan, R. et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367, 1444\u20131448 (2020).","journal-title":"Science"},{"key":"163_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215\u2013220 (2020).","journal-title":"Nature"},{"key":"163_CR8","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41564-021-00908-w","volume":"6","author":"TP Peacock","year":"2021","unstructured":"Peacock, T. P. et al. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets. Nat. Microbiol. 6, 899\u2013909 (2021).","journal-title":"Nat. Microbiol."},{"key":"163_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41368-020-0074-x","volume":"12","author":"H Xu","year":"2020","unstructured":"Xu, H. et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral. Sci. 12, 8 (2020).","journal-title":"Int. J. Oral. Sci."},{"key":"163_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104742","volume":"176","author":"B Coutard","year":"2020","unstructured":"Coutard, B. et al. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antivir. Res. 176, 104742 (2020).","journal-title":"Antivir. Res."},{"key":"163_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00128-22","volume":"96","author":"R Essalmani","year":"2022","unstructured":"Essalmani, R. et al. Distinctive roles of furin and TMPRSS2 in SARS-CoV-2 infectivity. J. Virol. 96, e0012822 (2022).","journal-title":"J. Virol."},{"key":"163_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41586-021-03237-4","volume":"591","author":"BA Johnson","year":"2021","unstructured":"Johnson, B. A. et al. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature 591, 293\u2013299 (2021).","journal-title":"Nature"},{"key":"163_CR13","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.abq2679","volume":"377","author":"JS Low","year":"2022","unstructured":"Low, J. S. et al. ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies. Science 377, 735\u2013742 (2022).","journal-title":"Science"},{"key":"163_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104873","volume":"181","author":"SY Kim","year":"2020","unstructured":"Kim, S. Y. et al. Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions. Antivir. Res. 181, 104873 (2020).","journal-title":"Antivir. Res."},{"key":"163_CR15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","volume":"183","author":"TM Clausen","year":"2020","unstructured":"Clausen, T. M. et al. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2. Cell 183, 1043\u20131057.e1015 (2020).","journal-title":"Cell"},{"key":"163_CR16","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1021\/acscentsci.1c00010","volume":"7","author":"L Liu","year":"2021","unstructured":"Liu, L. et al. Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2. ACS Cent. Sci. 7, 1009\u20131018 (2021).","journal-title":"ACS Cent. Sci."},{"key":"163_CR17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2404892121","volume":"121","author":"G Paiardi","year":"2024","unstructured":"Paiardi, G., Ferraz, M., Rusnati, M. & Wade, R. C. The accomplices: Heparan sulfates and N-glycans foster SARS-CoV-2 spike:ACE2 receptor binding and virus priming. Proc. Natl. Acad. Sci. USA 121, e2404892121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"163_CR18","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1055\/s-0040-1721319","volume":"120","author":"CJ Mycroft-West","year":"2020","unstructured":"Mycroft-West, C. J. et al. Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin. Thrombosis Haemost. 120, 1700\u20131715 (2020).","journal-title":"Thrombosis Haemost."},{"key":"163_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/chem.202202599","volume":"29","author":"M Parafioriti","year":"2023","unstructured":"Parafioriti, M. et al. Evidence for Multiple Binding Modes in the Initial Contact Between SARS-CoV-2 Spike S1 Protein and Cell Surface Glycans. Chemistry 29, e202202599 (2023).","journal-title":"Chemistry"},{"key":"163_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101507","volume":"298","author":"G Paiardi","year":"2022","unstructured":"Paiardi, G. et al. The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms. J. Biol. Chem. 298, 101507 (2022).","journal-title":"J. Biol. Chem."},{"key":"163_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1021\/acscentsci.1c01080","volume":"8","author":"SH Kim","year":"2022","unstructured":"Kim, S. H. et al. GlycoGrip: Cell Surface-Inspired Universal Sensor for Betacoronaviruses. ACS Cent. Sci. 8, 22\u201342 (2022).","journal-title":"ACS Cent. Sci."},{"key":"163_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrp.2023.101346","volume":"4","author":"SH Kim","year":"2023","unstructured":"Kim, S. H. et al. SARS-CoV-2 evolved variants optimize binding to cellular glycocalyx. Cell Rep. Phys. Sci. 4, 101346 (2023).","journal-title":"Cell Rep. Phys. Sci."},{"key":"163_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-84276-5","volume":"14","author":"J Froese","year":"2024","unstructured":"Froese, J. et al. Evolution of SARS-CoV-2 spike trimers towards optimized heparan sulfate cross-linking and inter-chain mobility. Sci. Rep. 14, 32174 (2024).","journal-title":"Sci. Rep."},{"key":"163_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2022.120167","volume":"299","author":"F Eilts","year":"2023","unstructured":"Eilts, F. et al. The diverse role of heparan sulfate and other GAGs in SARS-CoV-2 infections and therapeutics. Carbohydr. Polym. 299, 120167 (2023).","journal-title":"Carbohydr. Polym."},{"key":"163_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.synbio.2022.10.002","volume":"8","author":"L Jiang","year":"2023","unstructured":"Jiang, L. et al. Heparin mimetics as potential intervention for COVID-19 and their bio-manufacturing. Synth. Syst. Biotechnol. 8, 11\u201319 (2023).","journal-title":"Synth. Syst. Biotechnol."},{"key":"163_CR26","doi-asserted-by":"publisher","unstructured":"Mangiafico, M., Caff, A. & Costanzo, L. The Role of Heparin in COVID-19: An Update after Two Years of Pandemics. J. Clin Med. 11, https:\/\/doi.org\/10.3390\/jcm11113099 (2022).","DOI":"10.3390\/jcm11113099"},{"key":"163_CR27","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.2174\/1381612054367553","volume":"11","author":"M Rusnati","year":"2005","unstructured":"Rusnati, M., Oreste, P., Zoppetti, G. & Presta, M. Biotechnological engineering of heparin\/heparan sulphate: a novel area of multi-target drug discovery. Curr. Pharm. Des. 11, 2489\u20132499 (2005).","journal-title":"Curr. Pharm. Des."},{"key":"163_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0968-0004(88)90088-6","volume":"13","author":"B Casu","year":"1988","unstructured":"Casu, B., Petitou, M., Provasoli, M. & Sina\u00ff, P. Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans. Trends Biochem Sci. 13, 221\u2013225 (1988).","journal-title":"Trends Biochem Sci."},{"key":"163_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1042\/bj3470069","volume":"347","author":"A Hagner-Mcwhirter","year":"2000","unstructured":"Hagner-Mcwhirter, A., Lindahl, U. & Li, J. Biosynthesis of heparin\/heparan sulphate: mechanism of epimerization of glucuronyl C-5. Biochem J. 347, 69\u201375 (2000).","journal-title":"Biochem J."},{"key":"163_CR30","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1111\/j.1538-7836.2004.00866.x","volume":"2","author":"AM Gori","year":"2004","unstructured":"Gori, A. M. et al. Cytokine gene expression and production by human LPS-stimulated mononuclear cells are inhibited by sulfated heparin-like semi-synthetic derivatives. J. thrombosis Haemost. JTH 2, 1657\u20131662 (2004).","journal-title":"J. thrombosis Haemost. JTH"},{"key":"163_CR31","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1089\/adt.2011.0380","volume":"9","author":"M Jerabek-Willemsen","year":"2011","unstructured":"Jerabek-Willemsen, M., Wienken, C. J., Braun, D., Baaske, P. & Duhr, S. Molecular interaction studies using microscale thermophoresis. Assay. drug Dev. Technol. 9, 342\u2013353 (2011).","journal-title":"Assay. drug Dev. Technol."},{"key":"163_CR32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ymeth.2012.12.005","volume":"59","author":"SA Seidel","year":"2013","unstructured":"Seidel, S. A. et al. Microscale thermophoresis quantifies biomolecular interactions under previously challenging conditions. Methods 59, 301\u2013315 (2013).","journal-title":"Methods"},{"key":"163_CR33","doi-asserted-by":"publisher","first-page":"15870","DOI":"10.1002\/anie.202102717","volume":"60","author":"C Nie","year":"2021","unstructured":"Nie, C. et al. Polysulfates Block SARS-CoV-2 Uptake through Electrostatic Interactions*. Angew. Chem. Int Ed. Engl. 60, 15870\u201315878 (2021).","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"163_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1073","volume":"8","author":"E Braun","year":"2019","unstructured":"Braun, E. & Sauter, D. Furin-mediated protein processing in infectious diseases and cancer. Clin. Transl. Immunol. 8, e1073 (2019).","journal-title":"Clin. Transl. Immunol."},{"key":"163_CR35","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.csbj.2021.05.002","volume":"19","author":"ZP Schuurs","year":"2021","unstructured":"Schuurs, Z. P. et al. Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain. Computational Struct. Biotechnol. J. 19, 2806\u20132818 (2021).","journal-title":"Computational Struct. Biotechnol. J."},{"key":"163_CR36","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106267","volume":"39","author":"J Buchrieser","year":"2020","unstructured":"Buchrieser, J. et al. Syncytia formation by SARS-CoV-2-infected cells. EMBO J. 39, e106267 (2020).","journal-title":"EMBO J."},{"key":"163_CR37","doi-asserted-by":"publisher","unstructured":"Krylova, N. V. et al. Carrageenans and the carrageenan-echinochrome complex as anti-SARS-CoV-2 agents. Int. J. Mol. Sci. 26, https:\/\/doi.org\/10.3390\/ijms26136175 (2025).","DOI":"10.3390\/ijms26136175"},{"key":"163_CR38","doi-asserted-by":"publisher","unstructured":"Froba, M. et al. Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta. Int. J. Mol. Sci. 22, https:\/\/doi.org\/10.3390\/ijms222413202 (2021).","DOI":"10.3390\/ijms222413202"},{"key":"163_CR39","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1021\/acscentsci.1c01293","volume":"8","author":"SE Guimond","year":"2022","unstructured":"Guimond, S. E. et al. Synthetic heparan sulfate mimetic pixatimod (PG545) potently inhibits SARS-CoV-2 by disrupting the spike-ACE2 interaction. ACS Cent. Sci. 8, 527\u2013545 (2022).","journal-title":"ACS Cent. Sci."},{"key":"163_CR40","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1055\/a-1807-0168","volume":"122","author":"S Bertini","year":"2022","unstructured":"Bertini, S. et al. Pentosan polysulfate inhibits attachment and infection by SARS-CoV-2 in vitro: insights into structural requirements for binding. Thrombosis Haemost. 122, 984\u2013997 (2022).","journal-title":"Thrombosis Haemost."},{"key":"163_CR41","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1021\/jacsau.3c00042","volume":"3","author":"L Sun","year":"2023","unstructured":"Sun, L. et al. Well-defined heparin mimetics can inhibit binding of the trimeric spike of SARS-CoV-2 in a length-dependent manner. JACS Au 3, 1185\u20131195 (2023).","journal-title":"JACS Au"},{"key":"163_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellin.2022.100031","volume":"1","author":"D Chen","year":"2022","unstructured":"Chen, D., Zhao, Y. G. & Zhang, H. Endomembrane remodeling in SARS-CoV-2 infection. Cell Insight 1, 100031 (2022).","journal-title":"Cell Insight"},{"key":"163_CR43","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","volume":"603","author":"B Meng","year":"2022","unstructured":"Meng, B. et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature 603, 706\u2013714 (2022).","journal-title":"Nature"},{"key":"163_CR44","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/22221751.2021.2023329","volume":"11","author":"H Zhao","year":"2022","unstructured":"Zhao, H. et al. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells. Emerg. Microbes Infect. 11, 277\u2013283 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"163_CR45","doi-asserted-by":"publisher","first-page":"e1009246","DOI":"10.1371\/journal.ppat.1009246","volume":"17","author":"G Papa","year":"2021","unstructured":"Papa, G. et al. Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion. PLoS Pathog. 17, e1009246 (2021).","journal-title":"PLoS Pathog."},{"key":"163_CR46","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021107821","volume":"40","author":"J Koch","year":"2021","unstructured":"Koch, J. et al. TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells. EMBO J. 40, e107821 (2021).","journal-title":"EMBO J."},{"key":"163_CR47","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1023\/A:1007057826179","volume":"16","author":"HB Nader","year":"1999","unstructured":"Nader, H. B. et al. New insights on the specificity of heparin and heparan sulfate lyases from Flavobacterium heparinum revealed by the use of synthetic derivatives of K5 polysaccharide from E. coli and 2-O-desulfated heparin. Glycoconj. J. 16, 265\u2013270 (1999).","journal-title":"Glycoconj. J."},{"key":"163_CR48","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1016\/j.xphs.2022.06.004","volume":"111","author":"G Sahin","year":"2022","unstructured":"Sahin, G. et al. Antivirals and the potential benefits of orally inhaled drug administration in COVID-19 treatment. J. Pharm. Sci. 111, 2652\u20132661 (2022).","journal-title":"J. Pharm. Sci."},{"key":"163_CR49","doi-asserted-by":"publisher","unstructured":"Gatti, M. & De Ponti, F. Drug Repurposing in the COVID-19 era: insights from case studies showing pharmaceutical peculiarities. Pharmaceutics 13, https:\/\/doi.org\/10.3390\/pharmaceutics13030302 (2021).","DOI":"10.3390\/pharmaceutics13030302"},{"key":"163_CR50","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1111\/bcp.15212","volume":"88","author":"FMP van Haren","year":"2022","unstructured":"van Haren, F. M. P. et al. Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID-19: A multicentre case series of 98 patients. Br. J. Clin. Pharm. 88, 2802\u20132813 (2022).","journal-title":"Br. J. Clin. Pharm."},{"key":"163_CR51","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1160\/TH09-01-0012","volume":"102","author":"M Collino","year":"2009","unstructured":"Collino, M. et al. Effects of a semi-synthetic N-,O-sulfated glycosaminoglycan K5 polysaccharide derivative in a rat model of cerebral ischaemia\/reperfusion injury. Thrombosis Haemost. 102, 837\u2013845 (2009).","journal-title":"Thrombosis Haemost."},{"key":"163_CR52","doi-asserted-by":"crossref","unstructured":"Oreste, P. & Zoppetti, G. Semi-synthetic heparinoids. Handb. Exp. Pharmacol. 403\u2013422, (2012).","DOI":"10.1007\/978-3-642-23056-1_18"},{"key":"163_CR53","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/088391159601100403","volume":"11","author":"M Manzoni","year":"1996","unstructured":"Manzoni, M., Bergomi, S. & Cavazzoni, V. Production of K5 polysaccharides of different molecular weight by Escherichia Coli. J. Bioact. Compat. Polym. 11, 301\u2013311 (1996).","journal-title":"J. Bioact. Compat. Polym."},{"key":"163_CR54","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41417-021-00379-5","volume":"29","author":"M Rusnati","year":"2022","unstructured":"Rusnati, M. et al. Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF\/VEGFR2 in addition to Eph\/ephrin. Cancer Gene Ther. 29, 908\u2013917 (2022).","journal-title":"Cancer Gene Ther."},{"key":"163_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52201-w","volume":"9","author":"A Bugatti","year":"2019","unstructured":"Bugatti, A. et al. Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications. Sci. Rep. 9, 15768 (2019).","journal-title":"Sci. Rep."},{"key":"163_CR56","unstructured":"AMBER 2020 (University of California, San Francisco., 2020)."},{"key":"163_CR57","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier, J. A. et al. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696\u20133713 (2015).","journal-title":"J. Chem. Theory Comput."},{"key":"163_CR58","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/jcc.20820","volume":"29","author":"KN Kirschner","year":"2008","unstructured":"Kirschner, K. N. et al. GLYCAM06: a generalizable biomolecular force field. Carbohydrates. J. Comput. Chem. 29, 622\u2013655 (2008).","journal-title":"J. Comput. Chem."},{"key":"163_CR59","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"M Pekka","year":"2001","unstructured":"Pekka, M. & Lennart, N. Structure and Dynamics of the TIP3P, SPC, and SPC\/E Water Models at 298 K. J. Phys. Chem. A 105, 9954\u20139960 (2001).","journal-title":"J. Phys. Chem. A"},{"key":"163_CR60","doi-asserted-by":"crossref","unstructured":"Kr\u00e4utler, V., Van Gunsteren, W. F. & H\u00fcnenberger, P. H. Vol. 22 501\u2013508 (Journal of Computational Chemistry, Journal of Computational Chemistry, 2001).","DOI":"10.1002\/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V"},{"key":"163_CR61","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe, D. R. & Cheatham, T. E. PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J. Chem. Theory Comput. 9, 3084\u20133095 (2013).","journal-title":"J. Chem. Theory Comput."},{"key":"163_CR62","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 27\u201338 (1996).","journal-title":"J. Mol. Graph."},{"key":"163_CR63","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","volume":"18","author":"C Stringer","year":"2021","unstructured":"Stringer, C., Wang, T., Michaelos, M. & Pachitariu, M. Cellpose: a generalist algorithm for cellular segmentation. Nat. Methods 18, 100\u2013106 (2021).","journal-title":"Nat. Methods"},{"key":"163_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02535-1","volume":"18","author":"F Caccuri","year":"2020","unstructured":"Caccuri, F. et al. A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual. J. Transl. Med. 18, 362 (2020).","journal-title":"J. Transl. Med."},{"key":"163_CR65","doi-asserted-by":"publisher","unstructured":"Caccuri, F. et al. SARS-CoV-2 Infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells. Microorganisms 9, https:\/\/doi.org\/10.3390\/microorganisms9071438 (2021).","DOI":"10.3390\/microorganisms9071438"},{"key":"163_CR66","doi-asserted-by":"publisher","unstructured":"Bugatti, A. et al. SARS-CoV-2 Infects Human ACE2-negative endothelial cells through an \u03b1(v)\u03b2(3) integrin-mediated endocytosis even in the presence of vaccine-elicited neutralizing antibodies. Viruses 14, https:\/\/doi.org\/10.3390\/v14040705 (2022).","DOI":"10.3390\/v14040705"}],"container-title":["npj Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44298-025-00163-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44298-025-00163-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44298-025-00163-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:03:37Z","timestamp":1767967417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44298-025-00163-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["163"],"URL":"https:\/\/doi.org\/10.1038\/s44298-025-00163-4","relation":{},"ISSN":["2948-1767"],"issn-type":[{"value":"2948-1767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}